India allows exports of anti-malaria drug

Updated April 7 2020 - 3:43pm, first published 3:41pm
India will allow exports of anti-malaria drug hydroxychloroquine to the US.
India will allow exports of anti-malaria drug hydroxychloroquine to the US.

India will allow some exports of the anti-malaria drug hydroxychloroquine after US President Donald Trump urged New Delhi to release supplies of the drug seen as a possible treatment for COVID-19.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Launceston news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.